| 000 | 00807 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517083918.0 | ||
| 264 | 0 | _c20160801 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1546-1696 | ||
| 024 | 7 |
_a10.1038/nbt0316-217 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSheridan, Cormac | |
| 245 | 0 | 0 |
_aDrug developers refocus efforts on RAS. _h[electronic resource] |
| 260 |
_bNature biotechnology _cMar 2016 |
||
| 300 |
_a217-8 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 | _aBiotechnology |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xgenetics |
| 650 | 0 | 4 |
_aras Proteins _xgenetics |
| 773 | 0 |
_tNature biotechnology _gvol. 34 _gno. 3 _gp. 217-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nbt0316-217 _zAvailable from publisher's website |
| 999 |
_c25814788 _d25814788 |
||